The role of non-resolving inflammation in atherosclerosis

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880

Cytokine-mediated regulation of CXCR4 expression in human neutrophils

Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713

The M1 and M2 paradigm of macrophage activation: Time for reassessment

Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial

(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812

Alternative Activation of Macrophages: An Immunologic Functional Perspective

Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745

Macrophages in the Pathogenesis of Atherosclerosis

Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669

Mechanisms of plaque formation and rupture

Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391

The immune system in atherosclerosis

Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,389

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341

Efferocytosis in health and disease

Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066

The CD47-SIRPα Immune Checkpoint

Logtenberg, M. E. W., Scheeren, F. A., & Schumacher, T. N. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.011 · Cited by 760

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis

Chen, W., Schilperoort, M., Cao, Y., Shi, J., Tabas, I. A., & Tao, W. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00629-x · Cited by 544

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499

Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting

Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 440

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors

Lechner, K., von Schacky, C., McKenzie, A. L., Worm, N., Nixdorff, U., Lechner, B., Kränkel, N., Halle, M., Krauss, R. M., & Scherr, J. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319869400 · Cited by 390

The integration of inflammaging in age-related diseases

Fülöp, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 368

Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis

Tabas, I. A., & Bornfeldt, K. (2020) · Circulation Research · doi:10.1161/circresaha.119.315939 · Cited by 253

Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 223

Oxidation of polyunsaturated fatty acids to produce lipid mediators

Christie, W. W., & Harwood, J. L. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190082 · Cited by 231

RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice

Karunakaran, D., Nguyen, M.-A., Geoffrion, M., Vreeken, D., Lister, Z., Cheng, H. S., Otte, N., Essebier, P., Wyatt, H., Kandiah, J. W., et al. (2020) · Circulation · doi:10.1161/circulationaha.118.038379 · Cited by 220

LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation

Ye, Z.-M., Yang, S., Xia, Y., Hu, R., Chen, S., Li, B., Chen, S.-L., Luo, X., Mao, L., Li, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1409-4 · Cited by 209

Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation

Bai, R., Yao, C., Zhong, Z., Ge, J., Bai, Z., Ye, X., Xie, T., & Xie, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113165 · Cited by 197

Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment

He, Z., Chen, W., Hu, K., Luo, Y., Zeng, W., He, X., Li, T., Ouyang, J., Li, Y., Xie, L., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01687-1 · Cited by 191

Targeting Mechanosensitive Transcription Factors in Atherosclerosis

Niu, N., Xu, S., Xu, Y., Little, P. J., & Jin, Z. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.02.004 · Cited by 194

The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation

Schilperoort, M., Ngai, D., Sukka, S. R., Avrampou, K., Shi, H., & Tabas, I. A. (2023) · Immunological Reviews · doi:10.1111/imr.13214 · Cited by 184

Mouse Models for Atherosclerosis Research—Which Is My Line?

Oppi, S., Lüscher, T. F., & Stein, S. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00046 · Cited by 195

Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)

Tian, K., Li, J., & Xu, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.019 · Cited by 178

Inflammation Resolution: Implications for Atherosclerosis

Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 181

Nanoparticle Therapy for Vascular Diseases

Flores, A. M., Ye, J., Jarr, K.-U., Hosseini-Nassab, N., Smith, B. R., & Leeper, N. J. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311569 · Cited by 155

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation

Lechner, K., McKenzie, A. L., Kränkel, N., von Schacky, C., Worm, N., Nixdorff, U., Lechner, B., Scherr, J., Weingärtner, O., & Krauss, R. M. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0115 · Cited by 148

Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability

Yurdagul, A. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316233 · Cited by 138

Evidence for the Benefits of Melatonin in Cardiovascular Disease

Tobeiha, M., Jafari, A., Fadaei, S., Mirazimi, S. M. A., Dashti, F., Amiri, A., Khan, H. Z., Asemi, Z., Reiter, R. J., Hamblin, M. R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.888319 · Cited by 126

An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways.

Hu, Z., Guan, Y., Hu, W., Xu, Z., & Ishfaq, M. (2022) · PubMed Central · doi:10.22038/ijbms.2022.60380.13381 · Cited by 121

Inflammation, infection and atherosclerosis

Shah, P. K. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.01.004 · Cited by 111

Omega‐3 fatty acids, cardiovascular risk, and the resolution of inflammation

Bäck, M., & Hansson, G. K. (2019) · The FASEB Journal · doi:10.1096/fj.201802445r · Cited by 112

First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis

Trzeciak, A. J., Wang, Y., & Perry, J. S. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.001 · Cited by 109

N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1

Dong, G., Yu, J., Shan, G., Su, L., Yu, N., & Yang, S.-S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.731810 · Cited by 107

Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis

He, H., Han, Q., Wang, S., Long, M., Zhang, M., Li, Y., Zhang, Y., & Gu, N. (2023) · ACS Nano · doi:10.1021/acsnano.3c01420 · Cited by 107

The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy

Dabravolski, S. A., Sukhorukov, V. N., Kalmykov, V. A., Grechko, A. V., Shakhpazyan, N. K., & Orekhov, A. N. (2022) · Biomedicines · doi:10.3390/biomedicines10020254 · Cited by 96

HMGB1–C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis

Liu, T., Xiang, A., Peng, T., Doran, A. C., Tracey, K. J., Barnes, B. J., Tabas, I. A., Son, M., & Diamond, B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907490116 · Cited by 93

Inflammation and Cardiovascular Disease: The Future

Arnold, N., Lechner, K., Waldeyer, C., Shapiro, M. D., & Köenig, W. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.50 · Cited by 93

Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies

Porsch, F., Mallat, Z., & Binder, C. J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab285 · Cited by 88

The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection

Arnardottir, H., Thul, S., Pawelzik, S., Karadimou, G., Artiach, G., Gallina, A. L., Mysdotter, V., Carracedo, M., Tarnawski, L., Caravaca, A. S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142883 · Cited by 87

Mechanosensitive Channel PIEZO1 Senses Shear Force to Induce KLF2/4 Expression via CaMKII/MEKK3/ERK5 Axis in Endothelial Cells

Zheng, Q., Zou, Y., Teng, P., Chen, Z., Wu, Y., Dai, X., Li, X., Hu, Z., Wu, S., Xu, Y., et al. (2022) · Cells · doi:10.3390/cells11142191 · Cited by 84

Pro-resolving lipid mediators in vascular disease

Conte, M. S., Desai, T. A., Wu, B., Schaller, M. S., & Werlin, E. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97947 · Cited by 82

Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis

Geng, S., Zhang, Y., Lee, C., & Li, L. (2019) · Science Advances · doi:10.1126/sciadv.aav2309 · Cited by 80

Implications for the role of lipopolysaccharide in the development of atherosclerosis

Gorabi, A. M., Kiaie, N., Khosrojerdi, A., Jamialahmadi, T., Al‐Rasadi, K., Johnston, T. P., & Sahebkar, A. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.08.015 · Cited by 80

Epigenetics of chronic inflammatory diseases

Stylianou, E. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s129027 · Cited by 79

Current Development of Nano-Drug Delivery to Target Macrophages

Cai, D., Gao, W., Li, Z., Zhang, Y., Xiao, L., & Xiao, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10051203 · Cited by 74

Do patients benefit from omega-3 fatty acids?

Sherratt, S. C. R., Mason, R. P., Libby, P., Steg, P. G., & Bhatt, D. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad188 · Cited by 76

Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells

Chistiakov, D. A., Kashirskikh, D. A., Khotina, V. A., Grechko, A. V., & Orekhov, A. N. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111798 · Cited by 70

Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis

Wang, L., Li, H., Tang, Y., & Yao, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585285 · Cited by 67

Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases

Ramprasath, T., Han, Y., Zhang, D., Yu, C., & Zou, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.731701 · Cited by 62

C-type lectin Mincle mediates cell death–triggered inflammation in acute kidney injury

Tanaka, M., Saka-Tanaka, M., Ochi, K., Fujieda, K., Sugiura, Y., Miyamoto, T., Kohda, H., Ito, A., Miyazawa, T., Matsumoto, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192230 · Cited by 62

Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease

Xia, M., Yang, X., & Qian, C. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.10.043 · Cited by 62

Lipoxin Mimetics and the Resolution of Inflammation

Godson, C., Guiry, P. J., & Brennan, E. P. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-085407 · Cited by 59

Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives

Gouda, N. A., Alshammari, S. O., Abourehab, M. A. S., Alshammari, Q. A., & Elkamhawy, A. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01366-y · Cited by 59

An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease

Altamura, S., Pietropaoli, D., Lombardi, F., Pinto, R. D., & Ferri, C. (2023) · Biomedicines · doi:10.3390/biomedicines11113033 · Cited by 64

Inflammation in atherosclerotic cardiovascular disease

Shah, P. K., & Lecis, D. (2019) · F1000Research · doi:10.12688/f1000research.18901.1 · Cited by 58

Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis

Opoku, E., Traughber, C. A., Zhang, D. K. Y., Iacano, A. J., Khan, M. R., Han, J., Smith, J. D., & Gulshan, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715211 · Cited by 55

Millet shell polyphenols prevent atherosclerosis by protecting the gut barrier and remodeling the gut microbiota in ApoE −/− mice

Liu, F., Shan, S., Li, H., Shi, J., Hao, R., Yang, R., & Li, Z. (2021) · Food & Function · doi:10.1039/d1fo00991e · Cited by 53

Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis

Kasikara, C., Schilperoort, M., Gerlach, B. D., Xue, C., Wang, X., Zheng, Z., Kuriakose, G., Dorweiler, B., Zhang, H., Fredman, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145275 · Cited by 52

Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease

Teng, C., Lin, C., Huang, F., Xing, X., Chen, S., Ye, L., Azevedo, H. S., Xu, C., Wu, Z., Chen, Z., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.005 · Cited by 50

Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway

Fan, Y., Liu, J., Miao, J., Zhang, X., Yan, Y., Bai, L., Chang, J., Wang, Y., Wang, L., Bian, Y., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114106 · Cited by 50

Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans

Fan, L., Liu, J., Hu, W., Chen, Z., Lan, J., Zhang, T., Zhang, Y., Wu, X., Zhong, Z., Zhang, D., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00945-0 · Cited by 47

Mitochondrial bioenergetics and redox dysfunctions in hypercholesterolemia and atherosclerosis

Oliveira, H. C. F., & Vercesi, A. E. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100840 · Cited by 49

Netrin-1: A Modulator of Macrophage Driven Acute and Chronic Inflammation

Ziegon, L., & Schlegel, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010275 · Cited by 48

Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammation

Cimmino, G., Muscoli, S., Rosa, S. D., Cesaro, A., Perrone, M. A., Selvaggio, S., Selvaggio, G., Aimo, A., Pedrinelli, R., Mercuro, G., et al. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001450 · Cited by 45

Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment

Yang, B., Hang, S., Xu, S., Gao, Y., Yu, W., Zang, G., Zhang, L., & Wang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32073 · Cited by 46

The gut–immune axis during hypertension and cardiovascular diseases

Dinakis, E., O’Donnell, J. A., & Marques, F. Z. (2024) · Acta Physiologica · doi:10.1111/apha.14193 · Cited by 49

The Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis

Hua, Y., Zhang, J., Liu, Q., Su, J., Zhao, Y., Zheng, G., Yang, Z., Zhuo, D., Ma, C., & Fan, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831847 · Cited by 45

Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A

Zhang, L., Lu, L., Zhong, X., Yue, Y., Hong, Y., Li, Y., & Li, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.006 · Cited by 44

Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics

Wei, C., Jiang, Z., Li, C., Li, P., & Fu, Q. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202214655 · Cited by 43

C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway

Zhang, H., Gong, X., Ni, S., Wang, Y., Zhu, L., & Ji, N. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105934 · Cited by 43

Macrophages: First guards in the prevention of cardiovascular diseases

Nasser, M. I., Zhu, S., Huang, H., Zhao, M., Wang, B., Huang, P. C., Geng, Q., & Zhu, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117559 · Cited by 43

Animal models of human atherosclerosis: current progress

Poznyak, A. V., Silaeva, Y. Y., Orekhov, A. N., & Deykin, A. V. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209557 · Cited by 43

Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease

Schaller, M. S., Chen, M., Colas, R. A., Sorrentino, T. A., Lazar, A., Grenon, S. M., Dalli, J., & Conte, M. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016113 · Cited by 46

Diverse Epigenetic Regulations of Macrophages in Atherosclerosis

Yang, H., Sun, Y., Li, Q., Jin, F., & Dai, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.868788 · Cited by 46

Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy

Guo, L., Miao, Y., Wang, Y., Zhang, Y., Zhou, E.-F., Wang, J., Zhao, Y., Li, L., Wang, A., Gan, Y., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202204822 · Cited by 43

Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis

Jin, F., Li, J., Guo, J., Doeppner, T. R., Hermann, D. M., Yao, G., & Dai, Y. (2021) · European Heart Journal Open · doi:10.1093/ehjopen/oeab022 · Cited by 41

Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease

Gonzalez, A. L., Dungan, M. M., Smart, C. D., Madhur, M. S., & Doran, A. C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0284 · Cited by 42

Metabolic Consequences of Efferocytosis and Its Impact on Atherosclerosis

Yurdagul, A. (2021) · Immunometabolism · doi:10.20900/immunometab20210017 · Cited by 41

Lipid efflux mechanisms, relation to disease and potential therapeutic aspects

Castaño, D., Rattanasopa, C., Monteiro-Cardoso, V. F., Corlianò, M., Liu, Y., Zhong, A., Rusu, M., Liehn, E. A., & Singaraja, R. R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.013 · Cited by 37

Race-Based and Sex-Based Differences in Bioactive Lipid Mediators after Myocardial Infarction

Halade, G. V., Kain, V., Dillion, C., Beasley, T. M., Dudenbostel, T., Oparil, S., & Limdi, N. A. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12730 · Cited by 37

The “Common Soil Hypothesis” Revisited—Risk Factors for Type 2 Diabetes and Cardiovascular Disease

Silva, L. F., Vangipurapu, J., & Laakso, M. (2021) · Metabolites · doi:10.3390/metabo11100691 · Cited by 36

Regulatory mechanisms of Sesn2 and its role in multi-organ diseases

Wang, J., Wang, S., Xiao, M., Zhang, J., Wang, J., Guo, Y., Tang, Y., & Gu, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105331 · Cited by 36

Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies

Laera, N., Malerba, P., Vacanti, G., Nardin, S., Pagnesi, M., & Nardin, M. (2023) · Life · doi:10.3390/life13112128 · Cited by 34

A Pro-resolving Role for Galectin-1 in Acute Inflammation

Law, H. L., Wright, R. D., Iqbal, A. J., Norling, L. V., & Cooper, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00274 · Cited by 34

Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells

Schindler, L., Zwissler, L., Krammer, C., Hendgen-Cotta, U. B., Rassaf, T., Hampton, M. B., Dickerhof, N., & Bernhagen, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0420-242rrr · Cited by 34

Sialic acids promote macrophage M1 polarization and atherosclerosis by upregulating ROS and autophagy blockage

Hu, X., Li, Y., Chen, Q., Wang, T., Ma, L., Zhang, W., Yu, R., Zhang, J., Wan, J., Yu, C., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110410 · Cited by 34

Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis

Lobos, C. A., González, L., Bulnes, J. F., Figuls, M. R. I., Venturelli, P. M., & Rodríguez, G. M. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02291-4 · Cited by 33

Epigenetic Mechanisms in Vascular Inflammation: Modulation of Endothelial Adhesion Molecules and Endothelium-Leukocyte Adhesion

Calabriso, N., Massaro, M., Scoditti, E., Carluccio, C., Verri, T., & Carluccio, M. A. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2809194 · Cited by 34

Macrophage DNases Limit Neutrophil Extracellular Trap–Mediated Defective Efferocytosis in Atherosclerosis

Dhawan, U. K., Vartak, T., Englert, H., Russo, S., Vasconcellos, L. R. C., Singhal, A., Chakraborty, R., Bhagat, K. K., McDonnell, C. O., Connolly, M., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326353 · Cited by 35

Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment

Zhai, T., Wang, P., Hu, X., & Zheng, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3900835 · Cited by 34

Intraperitoneal Oil Application Causes Local Inflammation with Depletion of Resident Peritoneal Macrophages

Alsina‐Sanchís, E., Mülfarth, R. I., Moll, I., Mogler, C., Rodríguez‐Vita, J., & Fischer, A. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0650 · Cited by 32

Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy

Huang, C., Huang, W., Zhang, L., Zhang, C., Zhou, C., Wei, W., Li, Y., Zhou, Q., Chen, W., & Tang, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051083 · Cited by 32

The lymphocyte-to-monocyte ratio predicts intracranial atherosclerotic stenosis plaque instability

Wu, X., Huang, L., Huang, Z.-R., Lu, L., Luo, B., Cai, W., Liu, A.-M., & Wang, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915126 · Cited by 32

Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment

Arnold, N., & Köenig, W. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70020 · Cited by 33

Spatially Weighted Coronary Artery Calcium Score and Coronary Heart Disease Events in the Multi-Ethnic Study of Atherosclerosis

Shea, S., Navas‐Acién, A., Shimbo, D., Brown, E. R., Budoff, M. J., Bancks, M. P., Barr, R. G., & Kronmal, R. A. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011981 · Cited by 31

Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome

Trovato, E., Rubegni, P., & Prignano, F. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2093106 · Cited by 31

Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis

Lubrano, V., Ndreu, R., & Balzan, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021637 · Cited by 33

Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis

Pang, A. S., Dinesh, T., Pang, N. Y., Dinesh, V., Pang, K. Y., Yong, C. L., Lee, S., Yip, G. W. C., Bay, B., & Srinivasan, D. K. (2024) · Molecules · doi:10.3390/molecules29122873 · Cited by 31

Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics

Liu, Y., Li, C., Yang, X. P., Yang, B. T., & Fu, Q. (2024) · Biomaterials Science · doi:10.1039/d4bm00415a · Cited by 30

Linkage of circadian rhythm disruptions with Alzheimer's disease and therapeutic interventions

Madhamanchi, K., Zhang, J., & Melkani, G. C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.04.011 · Cited by 31

Molecular Pharmacology of Inflammation Resolution in Atherosclerosis

Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 31

Effects of neutrophil fate on inflammation

Xiao, Y., Yang, C. Z., Liu, W., Liu, K., Wang, Y., Xu, F., Wang, D., & Yang, Y. (2023) · Inflammation Research · doi:10.1007/s00011-023-01811-2 · Cited by 30

Friend or foe? Inflammation and the foreign body response to orthopedic biomaterials

Gibon, E., Takakubo, Y., Zwingenberger, S., Gallo, J., Takagi, M., & Goodman, S. B. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37599 · Cited by 29

Fine-tuning inflammation-resolution programs

Fredman, G., Sadhu, S., & Rymut, N. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000351 · Cited by 4

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341

Dysregulated Resolution of Inflammation in Atherosclerosis: Mechanistic Insights and Therapeutic Opportunities

Subramanian, M. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_361

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, G., Hellmann, J., Proto, J. D., Kuriakose, G., Colas, R. A., Dorweiler, B., Connolly, E. S., Solomon, R., Jones, D. M., Heyer, E. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12859 · Cited by 411

Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?

Fredman, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00205 · Cited by 22